These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 36874009)

  • 1. Natural products can modulate inflammation in intervertebral disc degeneration.
    Liu Z; Zhu J; Liu H; Fu C
    Front Pharmacol; 2023; 14():1150835. PubMed ID: 36874009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAPK /ERK signaling pathway: A potential target for the treatment of intervertebral disc degeneration.
    Zhang HJ; Liao HY; Bai DY; Wang ZQ; Xie XW
    Biomed Pharmacother; 2021 Nov; 143():112170. PubMed ID: 34536759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and differentiation factor-5 contributes to the structural and functional maintenance of the intervertebral disc.
    Feng C; Liu H; Yang Y; Huang B; Zhou Y
    Cell Physiol Biochem; 2015; 35(1):1-16. PubMed ID: 25547527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut-disc axis: A cause of intervertebral disc degeneration and low back pain?
    Li W; Lai K; Chopra N; Zheng Z; Das A; Diwan AD
    Eur Spine J; 2022 Apr; 31(4):917-925. PubMed ID: 35286474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the mechanisms of intervertebral disc degeneration: an exploration of the p38 MAPK signaling pathway.
    Zhang X; Zhang Z; Zou X; Wang Y; Qi J; Han S; Xin J; Zheng Z; Wei L; Zhang T; Zhang S
    Front Cell Dev Biol; 2023; 11():1324561. PubMed ID: 38313000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of IL-1β and TNF-α in intervertebral disc degeneration.
    Wang Y; Che M; Xin J; Zheng Z; Li J; Zhang S
    Biomed Pharmacother; 2020 Nov; 131():110660. PubMed ID: 32853910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular anatomy-based localization of intervertebral discs assisting needle puncture for constructing a mouse model of mechanical injury-induced lumbar intervertebral disc degeneration.
    Zhang L; Du G; Teng B; Shi X; He X; Li N; Chen Y; Xu R
    Biochem Biophys Res Commun; 2022 Dec; 634():196-202. PubMed ID: 36265418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic versus Asymptomatic Intervertebral Disc Degeneration: Is Inflammation the Key?
    Peng Y; Lv FJ
    Crit Rev Eukaryot Gene Expr; 2015; 25(1):13-21. PubMed ID: 25955814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mechanisms and Functions of GDF-5 in Intervertebral Disc Degeneration.
    Guo S; Cui L; Xiao C; Wang C; Zhu B; Liu X; Li Y; Liu X; Wang D; Li S
    Orthop Surg; 2021 May; 13(3):734-741. PubMed ID: 33817978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Factors in Intervertebral Disc Degeneration.
    Feng Y; Egan B; Wang J
    Genes Dis; 2016 Sep; 3(3):178-185. PubMed ID: 27617275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role and therapeutic implications of p53 in intervertebral disc degeneration.
    Wang Y; Hu S; Zhang W; Zhang B; Yang Z
    Cell Death Discov; 2023 Dec; 9(1):433. PubMed ID: 38040675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mechanism and Function of miRNA in Intervertebral Disc Degeneration.
    Wang C; Cui L; Gu Q; Guo S; Zhu B; Liu X; Li Y; Liu X; Wang D; Li S
    Orthop Surg; 2022 Mar; 14(3):463-471. PubMed ID: 35142050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fucoidan-loaded nanofibrous scaffolds promote annulus fibrosus repair by ameliorating the inflammatory and oxidative microenvironments in degenerative intervertebral discs.
    Yu Q; Han F; Yuan Z; Zhu Z; Liu C; Tu Z; Guo Q; Zhao R; Zhang W; Wang H; Mao H; Li B; Zhu C
    Acta Biomater; 2022 Aug; 148():73-89. PubMed ID: 35671874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative immune mechanisms and antioxidative therapies of intervertebral disc degeneration.
    Wei B; Zhao Y; Li W; Zhang S; Yan M; Hu Z; Gao B
    Front Bioeng Biotechnol; 2022; 10():1023877. PubMed ID: 36299288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROS: Crucial Intermediators in the Pathogenesis of Intervertebral Disc Degeneration.
    Feng C; Yang M; Lan M; Liu C; Zhang Y; Huang B; Liu H; Zhou Y
    Oxid Med Cell Longev; 2017; 2017():5601593. PubMed ID: 28392887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From drugs to biomaterials: a review of emerging therapeutic strategies for intervertebral disc inflammation.
    Yang S; Jing S; Wang S; Jia F
    Front Cell Infect Microbiol; 2024; 14():1303645. PubMed ID: 38352058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals.
    Kang L; Zhang H; Jia C; Zhang R; Shen C
    Front Pharmacol; 2022; 13():956355. PubMed ID: 35903342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment.
    Shnayder NA; Ashkhotov AV; Trefilova VV; Nurgaliev ZA; Novitsky MA; Petrova MM; Narodova EA; Al-Zamil M; Chumakova GA; Garganeeva NP; Nasyrova RF
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical
    Li Z; Gehlen Y; Heizmann F; Grad S; Alini M; Richards RG; Kubosch D; Südkamp N; Izadpanah K; Kubosch EJ; Lang G
    Front Bioeng Biotechnol; 2020; 8():583. PubMed ID: 32587853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rg1 inhibits nucleus pulposus cell apoptosis, inflammation and extracellular matrix degradation via the YAP1/TAZ pathway in rats with intervertebral disc degeneration.
    Yang YH; Gu XP; Hu H; Hu B; Wan XL; Gu ZP; Zhong SJ
    J Orthop Surg Res; 2022 Dec; 17(1):555. PubMed ID: 36539815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.